A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir

By  

Current Medicinal Chemistry, Vol. 20, Iss. 30, 2013-10 ,pp. : 3733-3742

Bentham Science Publishers

Access to resources Recommend Favorite

Hepatitis C therapy with HCV NS5B polymerase inhibitors

By Soriano Vincent   Vispo Eugenia   de Mendoza Carmen   Labarga Pablo   Fernandez-Montero Jose Vicente   Poveda Eva   Treviño Ana   Barreiro Pablo  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 9, 2013-06 ,pp. : 1161-1170

Informa Healthcare

Access to resources Recommend Favorite

QSAR and Molecular Modeling Studies on a Series of Indole-based Pyridone Analogues as HCV NS5B Polymerase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 8, 2016-10 ,pp. : 757-770

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting NS5B RNA-Dependent RNA Polymerase for Anti-HCV Chemotherapy

By  

Current Drug Targets - Infectious Disorders, Vol. 3, Iss. 3, 2003-09 ,pp. : 207-219

Bentham Science Publishers

Access to resources Recommend Favorite

Multiple Allosteric Pockets of HCV NS5B Polymerase and its Inhibitors: A Structure-Based Insight

By  

Current Bioactive Compounds, Vol. 4, Iss. 2, 2008-08 ,pp. : 86-109

Bentham Science Publishers

Access to resources Recommend Favorite